Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial.

• Autores: Lisa R. Metsch, Daniel J. Feaster, Lauren Gooden, Tim Matheson, Raul N. Mandler, Louise Haynes, Susan Tross, Tiffany Kyle, Dianne Gallup, Andrzej S. Kosinski, Antoine Douaihy, Bruce R. Schackman, Moupali Das-Douglas, Robert Lindblad, Sara C. Erickson, P. Todd Korthuis, Steve Martino, James L. Sorensen, José Szapocznik, Rochelle Walensky
• Localización: American journal of public health, ISSN 0090-0036, Vol. 102, Nº. 6, 2012, págs. 1160-1167
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objectives. We examined the effectiveness of risk reduction counseling and the role of on-site HIV testing in drug treatment. Methods. Between January and May 2009, we randomized 1281 HIV-negative (or status unknown) adults who reported no past-year HIV testing to (1) referral for off-site HIV testing, (2) HIV risk-reduction counseling with on-site rapid HIV testing, or (3) verbal information about testing only with on-site rapid HIV testing. Results. We defined 2 primary self-reported outcomes a priori: receipt of HIV test results and unprotected anal or vaginal intercourse episodes at 6-month follow-up. The combined on-site rapid testing participants received more HIV test results than off-site testing referral participants (P < .001; Mantel-Haenszel risk ratio = 4.52; 97.5% confidence interval [CI] = 3.57, 5.72). At 6 months, there were no significant differences in unprotected intercourse episodes between the combined on-site testing arms and the referral arm (P = .39; incidence rate ratio [IRR] = 1.04; 97.5% CI = 0.95, 1.14) or the 2 on-site testing arms (P = .81; IRR = 1.03; 97.5% CI = 0.84, 1.26). Conclusions. This study demonstrated on-site rapid HIV testing's value in drug treatment centers and found no additional benefit from HIV sexual risk-reduction counseling. [ABSTRACT FROM AUTHOR]